Ronald

G. Quisling,

MD

Persistent Arteriovenous Radlosurgery:

#{149} Keith

Nidus

R. Peters,

MD

#{149} William

A. Friedman,

MD

T

treatment of arteriovenous malformations (AVMs) of the brain has evolved in recent years from primarily a surgical approach to one HE

that

includes

the

adjunctive

use

of

stereotactic radiosurgery and embolization therapy (1-7). This multimodality approach presents new demands for magnetic resonance (MR) imaging (8,9). Pretreatment MR imaging must now enable clarification of the morphologic aspects of the afferent and efferent AVM blood supply, identification of the exact location of the AVM matrix, and estimation of the flow characteristics across all compartments of the nidus. It is no longer sufficient to limit the role of MR imaging to defining the presence or absence of a brain AVM. The effects of radiosurgery are being evaluated in current clinical practice, but much is already known. The preliminary results of radiosurgical treatment suggest that nidus obliteralion occurs in pial and deep AVMs in 30%-40% of cases within 1 year and 75%-85% within 2 years (4,5,7). Similar results are being observed in proton beam, gamma knife, and now linear accelerator-Linac (3,4,7,10) treatments.

Posttreatment MR imaging objectives include assessment of radiationinduced brain changes and residual AVM nidus blood flow (transnidus flow). MR imaging can help monitor the size of such lesions in a noninvasive manner (11-19). However, estimation of residual transnidus blood flow requires the use of special tech-

terms:

Arteriovenous malformations, 17.75 #{149}Brain, MR studies, 17.1214 blood vessels, flow dynamics, #{149} Magnetic resonance (MR), vascular 17.75

cerebral,

Cerebral 17.1214 studies,

Radiology

1991;

180:785-791

niques,

I

From

the

Departments

of Radiology

K.R.P., R.P.T.) and Neurosurgery versity

©

to R.G.Q.

RSNA,

1991

Medical

Center,

Uni-

Shands Hospital, J.H. Miller Health Center, Box J-374, Gainesville, FL 32610. From the 1990 RSNA srientific assembly. Received January 16, 1991; revision requested March 4; revision received March 20; accepted April 1. Address reprint re-

quests

of Florida

(R.G.Q.,

(W.A.F.),

P. Tart,

MD

Blood Flow In Cerebral Malformation after Stereotactic MR Imaging Assessment’

Stereotactic radiosurgery has become a major force in the treatment of arterioveous malformations (AVMs) of the brain. After treatment, obliteration of flow through the malformation occurs in 75%-85% of cases within 2 years, assuming the entire AVM nidus can be encompassed by the radiation field. Because the follow-up period is relatively long, a noninvasive means to assess residual transnidus blood flow is desirable. The authors report favorable findings after a comparative analysis of 85 posttreatment magnetic resonance images and 27 follow-up cerebral arteriograms in 34 patients treated with stereotactic radiosurgery. The authors found that transnidus flow can be determined from apparent signal intensity differences between tandem two-dimensional gradient-recalled echo images obtained first without and then with gradient moment nulling (flow compensation), with empirically derived pulse parameters. This method provides a means to monitor the reduction in AVM matrix size and to assess the extent of persistent arteriovenous shunting (ie, blood flow) across the nidus. Index

#{149} Roger

many

of which

are

relatively

new (eg, phase shift imaging and two- and three-dimensional MR angiography) (12-14). The merits of these methods remain to be proved. By contrast; gradient moment nulling (flow compensation) techniques are widely

available

to enhance by

signal

and

have

intensity

velocity-dependent

secondary

to nonstationary

phase

been

especially

that

associated

stant-velocity

blood

with

flow

con-

(16,17).

To our knowledge, no previously published study has employed twodimensional gradient-recalled echo (GRE) acquisitions performed in tandem first without flow compensation and then, immediately following, with flow compensation (see Patients and Methods). These acquisitions are performed

to estimate

residual

nidus

blood flow in radiosurgically treated vascular brain malformations. The goals of this study were to establish whether such an AVM MR imaging protocol could accurately depict the presence of residual flow across an AVM nidus, enable assessment of the progressive

diminution

of transnidus

flow over time, and enable determination of when complete thrombosis has occurred. PATIENTS

AND

METHODS

This comparative review of MR imaging and angiography included 34 patients Selected from a larger pool of patients who

had undergone

radiosurgery

to treat

cere-

bral AVMs. All patients in this study had undergone an initial angiographic evaluation followed by stereotactic radiosurgery

with

a Linac scalpel

Conn).

During

had been

(Philips,

the

Shelton,

follow-up

studied

with

period,

they

our AVM MR im-

aging protocol (ie, tandem GRE studies with and without flow compensation). A total of 85 posttreatment MR images

and 27 follow-up provided ysis.

cerebral

the basis

Thirteen

arteriograms

for this

patients

had

correlative

anal-

undergone

se-

rial MR imaging but had not completed follow-up cerebral arteriography. Follow-up MR images were generally obtamed at 6-month intervals after treatment, unless acute symptoms intervened. The distribution of MR images among patients is shown in Figure 1. At least one posttreatment

tamed

AVM

MR

in all 34 patients;

image

was

two images

ob-

were

used

degraded shifts

nuclei,

Abbreviations: mation,

GRE

=

AVM = arteriovenous gradient-recalled echo.

malfor-

785

obtained

in 24;

three

images

tamed in 17; four images six; and five posttreatment

were

obtained

bution

of MR

follow-up

were

Magnification

ob-

were obtained MR images

in

in one. The temporal images

period,

obtained

which

24 months,

is presented

MR images

were

distri-

ranged

from

compared

treatment

and

with

the

initial

an-

protocol angiography

in-

with

The cluded

clinical (radiosurgical) preliminary cerebral

formed

treatment

the

basis

planning.

was

scheduled

1-year

intervals

sisted.

Angiography

for

radiosurgical

Follow-up

sity

angiogra-

nidus

was

flow

per-

terminated

once

obliteration was achieved or no additional therapeutic response was apparent. To date, 27 follow-up angiograms have been obtained in 21 of 34 patients. Several patients have undergone more than one study,

while

others

complete

the

temporal

distribution

presented

(13

angiographic

MR

have

yet

The is

imaging

Studies

also

followed

a sagaxial

GRE studies region of the approximately

were

were

lim-

AVM

(Magnetom

performed

a repetition

msec,

a section

angle

of

msec,

four

time

thickness

signals

or

time

averaged,

mm, a flip of 12-15

a 256

were

not

with this method (Fig of nidus volumes were pretreatment calculations

the area of the stereotactic frame used to prescribe

786

#{149} Radiology

in seven

immagni-

Direct

tandem

[i7-i9])

over

the

sig-

GRE

the

changed

GRE

loca-

flow)

x 256

included

fields).

4) of calconsistent (minus

radiosurgical the radiation

ther-

treatment field. The second MR phy

but

recognition

thera-

comparison

imaging-angiografocused

on

whether

I

20

1

2

or

4

NO. OF MR SCANS

Figure tamed obtained

1. per

Distribution

5

PER PATIENT

of MR images

patient. Eighty-five in 34 patients.

ob-

images

were

no apparent

This

was

used

30 ‘u-i

for subtle

it added

of persistent

in five, in

10

isointense

when

to account

overall

mini-

30

difference in signal intensity could be discerned. Analog subtraction can be performed with the non-flow-compensated mask.

nidus

19 patients,

peutic consequence in the posttreatment period, provided that nidus volume progressively declines and that no additional nidus appears in contiguous regions outside the original

without

to either

as a subtraction

matched

of the

for

Re-

from hy-

image

was noted

imaging

15%

for three.

mally overestimated nidus size and underestimated nidus size seven compared with angiography. Errors of this degree have little

evinoted

clearly hyperintense (on the GRE image with flow compensation) relative to the brain in any part of the nidus. Negative evidence (indicative of no residual nidus

blood

within

25%

obtained

Positive flow was

intensities (on

in

similar

image

three,

im-

increased

precisely

second

signal

pointense

changes,

in the nidus volume calculations on any of the pre- or posttreatment MR images or angiograpic studies. This is especially important because radiosurgery usually preserves the parent circulation. Thus, residual flow persisted in both the pial arteries and veins in and around the AVM, even after transnidus flow had been eliminated.

treatment

on

when

little

to the

transnidus

z

flow. (liz

RESULTS

of 140-iSO of 4-5

an echo

400_500,

apy

the

effects

Siemens, Imaging parameters of these studies

malformation

Results culation with the

between

only occasionally

with

matrix, a field of view of 16-20 mm, and an interleaved series. Flow compensation was applied in the section-selection and readout directions only. Measured residual nidus volumes were calculated from the regions demonstrating enhancement on the tandem GRE images. The afferent and efferent portions of the vascular

of MR

size

precise

nulling.

for

within

sults

SP A2.i;

Iselin, NJ) MR imager. for the GRE component included

difference

study

2.5

a i.5-T (Signa Performance Plus GE Medical Systems, Milwaukee)

a i.0-T

moment

10%

and

values.

be a practical the

two,

for the

on stereotactic

It would

flow compensation)

T2-weighted imaging, and serial, axial, and GRE sequences performed first without and then with flow compensation gra-

minutes.

based

with flow compensation. dence of residual blood

angiograms

specific protocol that included routine ittal and axial Ti-weighted imaging,

either 3.3.8;

value

to determine

gradient

tions

3.

dients applied. The ited spatially to the nidus; each required

region

time-of-flight signal intensity

to

follow-up. of the

in Figure

Interval

of 34)

measured

a

ages was our primary diagnostic concern. A GRE AVM image was considered abnormal (transnidus flow present) if the lowsignal-intensity nidus (due to fast-flow,

at approximately

if residual

to the

within

cerebral

by applying

nal intensity measurements within the nidus were not performed, in part because the increase in signal intensity within an AVM nidus was seldom uniform across all pixels defining the nidus and because the observable conspicuity of the signal inten-

(in all 34 patients) and dynamic computed tomography performed in a stereotactic radiosurgical frame. Once digitized, these studies

the

fication of each plane for each intracranial AVM. Qualitative evidence of persistent nidus flow was defined as an apparent increase in signal intensity between the gradient images obtained first without and then

pre-

cerebral

on

corrected

an extrapolated

possibility

giograms.

phy

was

measurements.

in a blinded

posttreatment

reduction

This

10 to

manner by two neuroradiologists (R.G.Q., K.P.), and quantitation of residual nidus flow was tabulated. MR images were subsequently

25%

midcranial

2. All

in Figure

reviewed

were

the

during

effects

angiograms

The tial

data

step,

were

nidus

analyzed. size

mi-

As an

correlation

was

0

performed to ensure that what was perceived as nidus by tandem (with and without flow compensation) GRE studies did, in fact, correlate with cerebral parison

angiographic of mdus

size

findings. at MR

3.6

6.12

MONThS

Figure tamed

ment. patients

Comimaging

2. per

POST

12-18

Distribution of MR images patient during follow-up

Eighty-five (PTS.).

images

18-24

TREATMENT

were

obtreat-

obtained

in 34

and angiography was performed in 19 of the 34 patients who had undergone

both

AVM

MR imaging

proximity

cerebral (all

weeks

or less

hours).

These

arteriography

in close

within

and studies

a period

most

of 4

within were

with

angiography

performed

for

U) 0 z 4

24

to determine whether measured nidus volumes determined at MR imaging matched those obtained with cutfilm angiography. These data are presented in Figure 5. Close size correlation was observed. Among the 18 patients, nidus volume at MR imaging was within 5% of that measured

30

and

temporal

eight,

20

0 0 z

Ia

I

10

0

(U

I 3.6 SIX

Figure

3.

Distribution

(ANGIOS) obtained seven angiograms tients.

Ih 6.12

MONTH

12-18

18.24

INTERVALS

of angiograms

after treatment. were obtained

Twentyin 34 pa-

September

1991

or false-negative flow seen with ual AVM nidus

diagnosis MR imaging

documentation of absence of active AVM residua; this is graphically portrayed in Figure 6. Thus, MR imaging enabled correct prediction when there was no residual nidus flow before confirmation with angiography in each of seven cases, as illustrated in

the second set included patients who had angiographic evidence of persistent transnidus flow (flow-positive

this AVM MR imaging protocol could be used to correctly determine if residual nidus flow had been obliterated. To assess the likelihood of a false-positive (ie, flow-positive MR image but flow-negative angiogram)

status).

In the first instance, comparative analysis was performed on 21 preangiographic MR images obtained in seven patients, who, at follow-up an-

(ie, no but resid-

seen with angiography), two data sets were studied. The first set included patients with angiographic confirmation of obliterated nidus (ie, flow-negative status), and

giography,

dus bosis).

had

flow

no

residual

(ie, complete

AVM

A progressive

Figure

were

transni-

decline

residual mdus volume was on the MR images preceding

7. No

false-positive

observed

in this

diagnoses

limited

set of

throm-

patients.

in

In the second part of this evaluation, 42 preangiographic MR images from 18 patients who exhibited angio-

observed final

graphic

evidence

of persistent

trans-

nidus flow were analyzed. All MR images in this data set demonstrated a direct correlation with angiograms, correctly suggesting persistent nidus flow when, in fact, it did exist. In none of the cases with angiographic evidence of residual transnidus flow did results at MR imaging suggest completed thrombosis (ie, no falsenegative diagnoses). To evaluate whether temporally distinct studies reflected the anticipated progressive diminution of residual transnidus flow and to determine whether nidus measurements were consistent between serial MR imaging examinations, the measured residual nidus volumes (after 3 months to 2 years) were compared in 78 MR images obtained from 26 patients. Patients for whom only one

b.

d.

C.

Figure 4. Measurement which measurements cluded in measurements. subtraction angiogram

with

direct

anteroposterior

image obtained be hypointense

e

parameters for MR imaging-angiography correlation. of length (L) and height (H) of AVM nidus are obtained. This corresponds to methods used to calculate nidus illustrates means by which measurement of nidus width

without relative

and

lateral

flow compensation. to adjacent brain

measurements Fast-flow, tissue. AVM

of height,

width,

time-of-flight, nidus, depending

and and

(a) Lateral

Major

carotid

arterial

subtraction

pedicles

angiogram

and

venous

illustrates

efferent

vessels

means

volume for radiosurgical purposes. (b) Anteroposterior (W) is obtained. Angiographic AVM nidus volume

length

after

correcting

intravoxel dephasing on size, may be evident

for magnification. effects show on multiple

by

are not incarotid

is calculated (c) Two-dimensional GRE

the matrix (arrow) sections, although

of the AVM only one is

to

seen here. (d, e) Contiguous two-dimensional GRE images obtained with flow compensation. Both sections include portions of AVM nidus. Flow-related enhancement accentuated by compensatory gradient moment nulling is isointense or hyperintense in comparable regions identifled on the non-flow-compensated MR image (illustrated in c ) as part of AVM nidus. Length (L) and width (W) are determined by means of direct measurement, Efferent pial veins

Volume

180

and

height

(v in e), although

#{149} Number

3

is approximated enhancing,

by multiplying are not included

section thickness in these volume

by number measurements.

of sections

containing

evidence

of AVM

Radiology

matrix.

#{149} 787

posttreatment able were Nine

MR image excluded from

of the

26 patients

was availthe study.

nidus

underwent

two follow-up MR imaging examinations, ii underwent three examinations, five underwent four examinations, and one underwent five examinations. The anticipated therapeutic effect of stereotactic radiosurgery is a reduction in residual active nidus volume over 12-24 months. This decline in nidus size, although progressive, is often nonlinear. In most cases, little involution occurs within the first 6 months, barring acute venous thrombosis, as can occur when venous aneurysms are present (4-7).

Roughly 40% of cases proceed to nidus thrombosis within the first year, and another 40% develop a thrombus within 2 years. Some diminution in size is likely in nearly every patient by 2 years,

even

when

complete

oblitera-

tion has not been achieved. The concept of active residual nidus volume is emphasized, as postradiosurgical healing results in a mixed gliotic and fibrotic response, which is evident on MR images as regions of low signal intensity within the original nidus territory. Residual active nidus volumes are therefore determined by signal-intensity

changes

between

se-

rial GRE studies, as described in Patients and Methods. For the purpose of this analysis, serial MR images were considered as either an appropriate or inappropriate reflection of the anticipated reduction in nidus volume after radiosurgery. An appropriate imaging result was assigned when no change or a progressive

diminution

in nidus

vol-

ume was observed on the follow-up images compared with earlier images. An inappropriate label was assigned if an increase in nidus volume was observed

on

a later

image

compared

with preceding images. In essence, serial MR images indicated either no change or a progressive diminution in nidus volume, depending primarily on the interval from their treatment date in all patients studied. None of the cases demonstrated an increase in nidus volume in a treated area or enlargement of the nidus in an untreated area.

(9,20).

DISCUSSION Surgical

excision

788

#{149} Radiology

of AVMs

requires

about the arterial contribuof brain along travel. Embolizaknowledge of

characteristics,

that

the nidus has arteriocapillary In other

words,

is,

a complex barrier

14

or

larly

after

radiosurgical

in size

as they

regress

ating a resultant ity artifact that time-of-flight

magnetic can simulate

As such,

it may

residual fast-flow nents often seen malformations.

across

nidus,

cre-

susceptibilfast-flow, the

BETWEEN

Figure

5.

MR

20%

15%

t.#{248}us SiZE ANGlO

25%

VARIANCE

AND MR

imaging-angiography

van-

ance. Nidus volume was overestimated in five patients and underestimated in seven with MR imaging; findings of MR imaging correlated with those of angiography (ANGlO) in seven patients.

100

50 40 30

E

20

underestimate

(fistulized) in residual Phase

shift

methods)

compovascular imaging

can

10

3

6

Figure

6.

12

9

MONThS

POST

Progressive

apparent

decline

at follow-up

patients

with

15

18

21

in nidus

MR imaging

angiographic

24

TREATMENT

size

in seven

evidence

of AVM

thrombosis.

nidus,

may (in its current state of development) be adequate for a pretherapeutic diagnosis of arteriovenous shunting in AVMs, but until improvements in spatial resolution and processing time develop, it is unlikely that small residual posttreatment nidus volumes can be accurately predicted. MR angiography (two-dimensional, three-dimensional, and dephase rephase

I 10%

ESTIMATED

8

particularly with asymmetric T2weighted and standard GRE sequences. For these reasons, several special measures to detect residual nidus flow have been devised. Phase shift imaging is not widely available but does provide a slowly obtained, relatively coarse image that lends itself best for slower-flow imaging (2123).

I

sequences,

in the

effects

0

(after

and MR angiography for that matter, may suggest persistent AVM because of the observation of persistent enlargement of the vascular pedicle. In addition, as thrombosis occurs, hemoaccumulates

2

75

of the afferent (Fig 8d) often routine Ti- or

spin-echo

siderin

24

treatment,

treatment), the ectasia and efferent circulation persists. Consequently, T2-weighted

12 10

requires special consideration. Although vascular maiformations diminish

a.

embolization

therapy requires knowledge of whether the nidus is truly a malformation (complex arteriocapillary barrier) or part of an arteriovenous fistula (simplified arteriocapillary barrier) and whether venous aneurysms are present. These structural aspects of vascular malformations can be defined with standard MR imaging techniques in multiple planes, often in conjunction with MR angiography (three-dimensional or dephase and/or rephase techniques). However, delineation of the extent of residual blood flow through an AVM nidus, particu-

and/or

precise information source(s) of afferent tors and the surfaces which these vessels tion therapy requires

flow

whether simplified

image

flow in both arterial and venous structures. These techniques for posttreatment AVM imaging have several disadvantages. Because the AVM residua reside along the outer aspects of the prior AVM nidus, it is useful to image both the thrombosed (ie, stationary) and nonthrombosed portions of the

nidus

for orientation. This relationis lost with all MR angiographic subtraction techniques. Both two- and three-dimensional techniques use short repetition times and depend on orthogonal blood flow relative to the section-select orientation to provide in-flow (time-of-flight) ship

signal intensity maximal-signal-intensity

for

subtraction and projection

methods of display. Smaller vessels, both arterial and venous (which form the AVM matrix), tend to reside nearly in-plane; they create less signal-intensity with adjacent

difference

compared

tissue, particularly at short repetition times, and therefore are frequently subtracted from the image. Both two- and three-dimensional MR angiographic methods tend to image the larger afferent and efferent components of vascular malformations rather than the nidus per Se. In addition, subacute blood products can sufficiently shorten Ti to artifactually appear as flowing blood at three-dimensional

MR

angiography.

Finally, in the late posttreatment period, residual ectasia of former afferent or efferent vessels can persist. Because

the

nidus

is often

not

seen

September

1991

compared with the section-select and phase directions). Gradient moment nulling techniques work best when flow-related enhancement is maximized. A velocity window is created on the basis of the relationship of section thickness to repetition time. The parameters in this study evolved from empiric observations made in an attempt to maximize velocity-dependent flow-related enhancement within the matrix of the vascular malformation. Difficulties immediately arise during attempts to quantify flow velocities within cerebral AVMs. These lesions

C.

typically

display

flow-rate

heterogeneity between patients and even within each AVM. A rough approximation of flow velocity is available from contrast agent clearance times

d. Figure 7. Flow-compensated enhancement of residual nidus in presence of subacute thrombus. (a) Axial GRE image obtained with flow compensation. Image was obtained 18 months after treatment but 2 months after development of spontaneous partial thrombosis in efferent AVM circulation (ie, clotted venous varix). Comparison of GRE images without (not illus-

trated) and with flow compensation eral aspect of matrix (arrow) and was

considered

residual

flow

and

revealed no intensity latter,

clear evidence change along

residual

thrombus.

of enhancement along left aspect (arrowhead). Flow-through

residual

right latFormer nidus

(ar-

row) was documented angiographically (see b). (b) Lateral vertebral angiogram obtained after MR image shown in a. Residual transnidus blood flow (arrow) is evident in the dorsal mesencephalic region, confirming what was predicted with MR imaging (see a). (c) Axial GRE image obtained with flow compensation 22 months after treatment. This section was obtained in the same manner and at the same level as a, but 4 months later. It demonstrates persistent hyperintensity compared with the residual clot on the left (arrowhead) but no marginal enhance-

ment on the right (arrow) lateral aspect. MR imaging findings were indicative of complete AVM thrombosis, which was confirmed angiographically (see d). (d) Lateral vertebral anglogram obtained after MR image shown in c. No residual transnidus blood flow can be detected, as correctly

predicted

by images

with

and

without

better with MR angiography, such techniques may suggest residual flow even after nidus obliteration has occurred. Such MR angiographic techniques were not available across the entire study period, creating an incomplete data set. Comparison of MR angiography with the AVM MR imaging protocol presented herein will be the subject of further investigation. Serial two-dimensional GRE imaging combined with flow compensation techniques in the manner described earlier has remained our method of assessment of persistence Volume

180

#{149} Number

3

flow-compensated

GRE

imaging

protocol.

of the arteriovenous shunt across the AVM nidus. This method has some strengths and some weaknesses, as do all the noninvasive means to assess residual intracerebral blood flow in AVMs. Gradient techniques, for

prove

signal

ity-dependent

moment the most

lost

nulling part, im-

to intravoxel,

phase

shifts

velocsecondary

to nonstationary nuclei. They are best suited to correct the phase shifts associated with in-plane linear (intravascular) flow in the readout direction (due to the longer period during which the readout gradient is in effect

observed

during

microcatheter-

izations of brain AVMs before embolization therapy and from transcranial Doppler examination. Reported distal middle cerebral artery flow rates range from 30 to 50 cm/sec in adults who have undergone endarterectomy (24). Because flow velocity is inversely proportional to the relationship between the squares of the diameters of the arteries and because it is not uncommon for the afferent and efferent AVM vessels to dilate threefold, the resulting flow velocity in both the afferent and efferent limbs (secondary to shunting)

across

the

AVM

might diminish ninefold resulting in effect flow cm/sec.

These

lated ties

observations

approximations prompted

GRE

imaging

study.

These

the

matrix

to iO-fold, rates of 3-5 and

of flow selection

parameters parameters

calcu-

velociof the

used

in this

provided

a

velocity profile that best captured the flow-related enhancement within the nonfistula components of most cerebral AVMs imaged in this study. Such transnidus flow rates are at best an approximation and are probably low. In a presentation at the i990 RSNA scientific assembly, Turski et al (25) reported data from phase-contrast MR imaging techniques in untreated cerebral AVMs that approximated afferent circulation flow rates at 200 cm/sec and venous flow rates at 20 cm/sec.

These

techniques,

in all likeli-

hood, measure different aspects of transnidus flow and help determine flow rates in patients in different clinical states. It is likely that radiosurgery may have a pronounced effect on overall transnidus flow rates. Nonlinear flow generally obviates the flow-related enhancing effects of gradient moment nulling. However, as observed

in this

study,

transnidus

Radiology

#{149} 789

flow is sufficiently in-plane and ciently linear to create detectable nal-intensity

differences

between

suffisigse-

rial GRE images that vary only in the application of the gradient moment nulling techniques. As one would expect, all flow-related phase shifts across the nidus are not corrected; neither are all corrected uniformly. However, the clinical object of such MR flow imaging is to detect the presence of any residual flow across the irradiated nidus and to detect whether there is residual flow outside the treatment field. The latter may occur if the margins of the original nidus were not exactly appreciated on the initial angiogram and were not encompassed by the radiation field. Data from this series indicate that signal-intensity change from hypointense (relative to cerebral parenchyma) to either isointense or hyperintense within the nidus is indicative of transnidus flow. The smallest region of residual transnidus flow was 1.5 mm

in cross-sectional

diameter.

(assuming

Ti-weighted

pulse

sequences, as described previously) performed during this intermediate phase of treatment will reveal a central region of low signal intensity (secondary to gliosis, fibrosis, and hemosiderin deposition) and evidence of marginal flow-related enhancement on GRE studies with and without flow compensation. These features are illustrated in Figures 7 and 8. The imaging of thrombosed portions of an AVM with GRE imaging is very helpful to identify residual flow once significant nidus reduction has occurred. These morphologic data are lost with MR angiography. Additional problems arise if intervening thrombus formation occurs within the matrix of the malformation. Acute thrombus most commonly forms within venous aneurysms associated with the efferent drainage system. The presence of blood products will generally add hyperintense signal intensity to the central and efferent portions of the nidus. It has been our experience in a few cases that flow-compensated GRE techniques, despite the presence of subacute 790

#{149} Radiology

C.

In

cases in which no residual flow was proved angiographically, no signalintensity change was observed in any part of the prior AVM matrix. After radiosurgical treatment, cerebral AVMs progressively decrease in size, becoming more gliotic and fibrotic. These changes generally appear centrally. As a consequence, the residual nidus tends to reside along the periphery of the AVM matrix. MR imaging

a.

b.

d.

Figure

8.

MR

imaging-angiographic

over 20 months. ment demonstrates rowheads) anterolaterally,

obtained

and

evidence which

anterolateral

treatment

gram

seen

radiosurgery of original

obtained blood

confirms nidus.

at follow-up after

which

after

was

flow.

tery (arrow), formerly treatment, even after

posttreatment

note

part of afferent nidus has been

subtle

smaller, lenged.

residual

patent

the technique Our current

nidus

chalsug-

gests that persistent residual transnidus flow can be reliably detected as

the 1.5-2

residual patent nidus mm in cross-sectional

(c) Axial

approaches diameter.

no

MR imaging residual

longer

ectasia

of at least

completed

carotid

anglo-

of residual

one

suprasylvian

if the

of the

AVM

flow

indicate

ar-

is not uncommon

Conceivably, residua

pre-

with enhance-

absence

of ectasia

(arrow)

from

displays

d). (d) Lateral

confirms

nidus

obtained

(a). MR features (see

nidus flow angiogram

reduced

GRE image

Section

image

AVM

size

after treatof AVM (ar-

residual carotid

substantially

pedicle. This degree thrombosed.

becomes

is further experience

of nidus

12 months portion

of residual

was

angiographically

blood products, allowed detection of persistent marginal blood flow, as illustrated in Figure 7. Results of the study indicate the accuracy of this method in determining transnidus flow. Certainly, flow persistence within an AVM matrix larger than 5 mm in cross-sectional diameter is relatively easy to detect. As the

size

treatment.

posttreatment

However,

the presence

MR imaging.

confirmed

diminution

(arrow), confirming in b. (b) Lateral cerebral

Nidus

radiosurgical

20-month

of progressive

with flow compensation representing thrombosed

enhancement proved

on the 12-month

thrombosis,

transnidus

after aspect

20 months

(arrow)

nidus

of peripheral is angiographically

size, as predicted

compensation

ment

(a) Axial GRE image obtained central low signal intensity

12 months

in the

confirmation

after

posttreatment undergo

fistuliza-

tion, the flow rate across the fistula could exceed the velocity window of the technique, and thus no signal would be captured with use of this method. This has not occurred in our series

the

to date.

nidus

source

of error,

ther

as more

dus

obliteration

ever,

our

fistulization

a likely it will

cases

be

with

studied

fur-

complete

ni-

How-

to date

indicates

flow-compensated with a reasonably

of reliability,

of

eventual

accumulate.

experience

that tandem, studies can,

degree

Because

remains

predict

GRE high

transni-

September

1991

dus flow or lack of flow in most all complex matrix AVMs. U

apy: the role of MR. Neuroradiology

if not 9.

MR imaging

References 1.

2.

tentonal

Marks MP, Delapaz RL, Fabrikant JI, et al. Intracranial vascular malformations: imaging of charged particle radiosurgery. I. ResuIts of therapy. Radiology 1988; 168:447455. Marks MP, Delapaz RL, FabrikantJl, et al. Intracranial vascular malformations: imaging of charged particle radiosurgery. II. Complications. Radiology 1988; 168:457-

10.

11.

462.

3.

4.

Fabrikant JI, Lyman JT, Frankel KA. Heavy charged particle Bragg peak radiosurgery for intracranial vascular disorders. Radiat Res 1985; 8(suppl):S244-S258. Lunsford LD, FlickingerJ, Coffey RJ. Ste-

reotactic gamma North American 5. 6.

7.

Arch Neurol 1990; 47:169-175. Friedman W. LINAC Radiosurgery. Neurosurg Clin North Am 1990; 1:991-1008. Wolkov HB, Bagshaw M. Conventional radiation therapy in the management of arteriovenous malformations of the central nervous system. Int J Radiat Oncol Biol Phys 1988; 15:1461-1464. Levy R, FabricantJ, Frankel K, Phillips M, Lyman J. Stereotactic heavy charged partide bragg peak radiosurgery for the treat-

ment

8.

knife radiosurgery: initial experience in 207 patients.

of intracranial

arteriovenous

mations in childhood and adolescence. Neurosurgery 1989; 24:841-850. Jabour BA, DionjE, Lufkin R, et al. rovascular lesions and endovascular

12.

#{149} Number

3

H, Van

Intracranial and clinical

Y, et al.

R, Wentz

K, Mattle

H, et aL

In-

arteriovenous

malformations:

evaluation

with

MR angiography 1989; 173:831-

Radiology

a special course in MR 1990. Oak Brook, Radiological Society of North America, 1990; 57-62.

Ill:

Atlas

RI.

AS, Fram

Neuther-

Needell

WM, Maravilla

aging

in vascular

dient

recalled

9:637-642. Waluch V.

KR.

MR flow im-

malformations

acquisition. Magnetic

flow. Semin

AJNR resonance

Neurol

using 1988;

Dawson Treatment

malformations:

A,

D. MR

1985; 156:383-

T, Yamada

R III, Tarr R, Hecht of arteriovenous

11:857-864. Dumoulin C, Souza Three-dimensional

raphy. 22.

23.

25.

EK, Grossman

L, Uske

G, Norman

Radiology

of the brain with combined and stereotactic radiosurgery.

Masaryk T. MR Angiography. In: Kressel HY, Modic MT, Murphy WA, eds. Syllabus:

1988; 169:455-461.

16.

20.

24.

SW, Mark

vascular

S. Nishimura

Laub

Magn

Reson

G, Kaiser

W.

gradient

tracerebral

selective

389. Imakita

Pleghos

M, Dooms

N, et al.

Cerebral vascular malformations: applications of magnetic resonance imaging to differential diagnosis. Neuroradiology 1989; 31:320-325.

MR angiogra-

Vascular intracranial lesions: applications of gradient echo MR imaging. Radiology

malfor-

19.

Fraeyenhoven

837.

15.

W, Lemme

and CT imaging.

1990; 175:443-448.

and venography. 14.

Kucharczyk Intracranial

of supraAmJ Roent-

vascular lesions: optievaluation of three-

time-of-flight

phy. Radiology Edelman

18.

21.

211-220. Marchal G, Bosmans

of blood

180

Kikuchi

genol Souhami L, Olivier A, Podgorsak EB, Hazel I, Pla M, Tampieri D. Dynamic stereotactic radiosurgery in arteriovenous malformation: preliminary treatment results. Cancer 1990; 66:15-20. Edelman RR, Mattle HP, Atkinson DJ, et al. Cerebral blood flow: assessment with dynamic contrast enhanced T2*weighted MR imaging at 1.5 T. Radiology 1990; 176:

mization dimensional

17.

Volume

CM,

in the management

intracranial AVMs. 1988; 150:1143-1153.

L, et al.

13.

1989;

Brant Zawadzki

31:341-345. Smith HJ, Strother

S. et al. malformations

embolization AJNR 1990;

S, Walker M, Wagle W. phase contrast angiog-

Med 1989; 9:139-149. MR angiography with refocusing. J Comput As-

motion

sist Tomogr 1988; 12:377-382. Lenz G, Haacke E, Masark T, Laub

plane vascular imaging: pulse design and strategy. Radiology

G. Insequence 1988; 166:

875-882. HalseyJ, Morawetz

H, Gelmon

S.

velocity

in the

McDowell R.

Blood

middle

cerebral artery and regional cerebral blood flow during carotid endarterectomy. Stroke 1989; 20:5358. Turski PA, Korosec FR, Partington CR, Strother CM, Graves VB, Mistretta CA. Cardiac-gated and variable-velocity-phase MR angiography for evaluation of intracranial aneurysms and arteriovenous malformations (abstr). Radiology 1990; 177(P):281.

gra-

imaging

1986; 6:65-71.

Radiology

#{149} 791

Persistent nidus blood flow in cerebral arteriovenous malformation after stereotactic radiosurgery: MR imaging assessment.

Stereotactic radiosurgery has become a major force in the treatment of arteriovenous malformations (AVMs) of the brain. After treatment, obliteration ...
2MB Sizes 0 Downloads 0 Views